Genesis Research Services
Welcome,         Profile    Billing    Logout  
 3 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Macdonald, Heather
NCT05837234: Ultra Low Frequency Spinal Cord Stimulation for Chronic Low Back Pain

Recruiting
N/A
55
RoW
ULF SCS
Presidio Medical, Inc
Chronic Pain, Chronic Low-back Pain
09/24
06/25
PREDICT, NCT03448926: The Registry:

Recruiting
N/A
3000
US
Treatment Recommendation Surveys, 7-gene biosignature
PreludeDx, University of South Florida
DCIS
12/25
12/35
Volschenk, Willem
NCT05837234: Ultra Low Frequency Spinal Cord Stimulation for Chronic Low Back Pain

Recruiting
N/A
55
RoW
ULF SCS
Presidio Medical, Inc
Chronic Pain, Chronic Low-back Pain
09/24
06/25
Russo, Marc
NCT06291857: A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Not yet recruiting
3
7950
RoW
CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, COVID-19 and influenza combination, Novavax COVID-19 Vaccine, Novavax SARS-CoV-2 rS vaccine, tNIV Vaccine, Trivalent Nanoparticle Influenza Hemagglutinin Vaccine, Fluzone High Dose, Fluzone HD
Novavax
COVID-19
03/25
04/25
NCT05344157: A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis

Active, not recruiting
1/2
54
RoW
XSTEM-OA
Xindu Pty Ltd, Xintela AB
Osteoarthritis, Knee
06/25
06/25
NCT05177354: Medtronic Closed-Loop Spinal Cord Stimulation System

Active, not recruiting
N/A
94
RoW
Inceptiv
MedtronicNeuro
Low Back Pain, Leg Pain, Upper Limb Pain
05/23
08/25
RECLAIM, NCT06450444: The Study.

Recruiting
N/A
62
Europe, RoW
PRIMUS
Salvia BioElectronics
Chronic Migraine, High Frequency Episodic Migraine
10/25
02/27
Raj, Anna' Dorai
CHAPPII, NCT05942911: Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis

Recruiting
2
128
RoW
IHL-675A, Cannabidiol, CBD, Epidiolex, Epydiolex, Hydroxychloroquine, HCQ, Plaquenil, Placebo
Incannex Healthcare Ltd
Rheumatoid Arthritis
10/24
12/24
Russo
PREVAIL, NCT05202509 / 2021-005092-39: Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active, not recruiting
3
9541
Europe, Canada, Japan, US, RoW
Obicetrapib, Placebo
NewAmsterdam Pharma, Monash University
Atherosclerotic Cardiovascular Disease
11/26
11/26
RECLAIM, NCT06450444: The Study.

Recruiting
N/A
62
Europe, RoW
PRIMUS
Salvia BioElectronics
Chronic Migraine, High Frequency Episodic Migraine
10/25
02/27
Edinburg, Yair
NCT06291857: A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine

Not yet recruiting
3
7950
RoW
CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, COVID-19 and influenza combination, Novavax COVID-19 Vaccine, Novavax SARS-CoV-2 rS vaccine, tNIV Vaccine, Trivalent Nanoparticle Influenza Hemagglutinin Vaccine, Fluzone High Dose, Fluzone HD
Novavax
COVID-19
03/25
04/25
DehydraTECH, NCT06648031: Comparison of the Safety, Efficacy and Pharmacokinetics of -CBD and -GLP1 Agonists Alone or in Combination, in Overweight or Obese, Pre- and Type 2 Diabetic Participants

Not yet recruiting
1
80
RoW
Arm 1 - DehydraTECH-CBD alone, Arm 2 - DehydraTECH-semaglutide alone, Arm 3 - DehydraTECH-CBD in combination with DehydraTECH-semaglutide, Arm 4 - Rybelsus medication (semaglutide) alone
Lexaria Bioscience Corp.
Type2diabetes
05/25
09/25

Download Options